Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study

Purpose The optimal treatment after neoadjuvant chemoimmunotherapy for patients with stage III non-small cell lung cancer (NSCLC) is unclear. This study aimed at comparing the efficacy and safety of chemoradiotherapy and surgery after neoadjuvant chemoimmunotherapy in stage III NSCLC. Materials and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer Immunology, Immunotherapy : CII Immunotherapy : CII, 2024-05, Vol.73 (7), p.120, Article 120
Hauptverfasser:	Guan, Song, Sun, Jifeng, Wang, Yuan, Han, Sibei, Chen, Chen, Yue, Dongsheng, Huang, Yubei, Ren, Kai, Wang, Jun, Zhao, Lujun
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Research Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - therapy Chemoradiotherapy Chemoradiotherapy - methods Female Humans Immunology Immunotherapy - methods Lung cancer Lung Neoplasms - mortality Lung Neoplasms - pathology Lung Neoplasms - therapy Male Medical prognosis Medicine Medicine & Public Health Metastases Middle Aged Neoadjuvant Therapy - methods Neoplasm Staging Non-small cell lung carcinoma Oncology Patients Prognosis Regression analysis Retrospective Studies Small cell lung carcinoma Surgery Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!